Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
0.9260
-0.0210 (-2.22%)
At close: Mar 20, 2026, 4:00 PM EDT
0.9110
-0.0150 (-1.62%)
After-hours: Mar 20, 2026, 7:04 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $104.32 million as of March 20, 2026. Its market cap has increased by 12.33% in one year.
Market Cap
104.32M
Enterprise Value
95.95M
1-Year Change
12.33%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $104.32M, an increase of 49.53%. That is a compound annual growth rate of 5.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 105.97M | 11.46% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China SXT Pharmaceuticals | 196.09M |
| Aurora Cannabis | 195.48M |
| Journey Medical | 193.21M |
| Organigram Global | 190.18M |
| Anika Therapeutics | 189.08M |
| Lifecore Biomedical | 155.49M |
| Alpha Teknova | 148.44M |
| Assertio Holdings | 88.17M |